Published in Medicine and Law Weekly, May 19th, 2006
This patent, number 09/344427, further strengthens Avicena's intellectual property portfolio, particularly as it relates to the company's growing dermaceutical business. Avicena has already secured patent protection for this use in the United States (U.S. 6,242,491 B1) and a similar patent application is presently pending in Europe.
Avicena possesses a substantial intellectual property...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.